Danh mục

Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: A phase II single-arm study

Số trang: 8      Loại file: pdf      Dung lượng: 641.41 KB      Lượt xem: 11      Lượt tải: 0    
Thư viện của tui

Xem trước 2 trang đầu tiên của tài liệu này:

Thông tin tài liệu:

Treatment of acute myeloid leukemia (AML) in elderly patients remains a great challenge. In this prospective single arm study (ChiCTR-OPC-15006492), we evaluated the efficacy and safety of a novel consolidation therapy with low-dose decitabine (LD-DAC) priming with intermediate-dose cytarabine (ID-Ara-C) followed by umbilical cord blood (UCB) infusion in elderly patients with AML.
Nội dung trích xuất từ tài liệu:
Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: A phase II single-arm study

Tài liệu được xem nhiều: